Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae

Introduction: Polymyxin B is a last-line therapy for carbapenem-resistant microorganisms. However, a lack of clinical pharmacokinetic/pharmacodynamic (PK/PD) data has substantially hindered dose optimization and breakpoint setting. Methods: A prospective, multi-center clinical trial was undertaken w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Zhenwei, Liu, Xiaofen, Du, Xiaoxing, Chen, Huiying, Zhao, Feng, Zhou, Zhihui, Wang, Yu, Zheng, Yang, Bergen, Phillip J., Li, Xi, Sun, Renhua, Fang, Li, Li, Wanzhen, Fan, Yaxin, Wu, Hailan, Guo, Beining, Li, Jian, Yu, Yunsong, Zhang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800617/
https://www.ncbi.nlm.nih.gov/pubmed/36588676
http://dx.doi.org/10.3389/fphar.2022.975066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800617/
https://www.ncbi.nlm.nih.gov/pubmed/36588676
http://dx.doi.org/10.3389/fphar.2022.975066

Ejemplares similares